Offer - Urjas Oil for just ₹ 1
Revolade 50 Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Thrombocytopenia and ITP. Other than this, Revolade 50 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Revolade 50 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Revolade 50 Tablet include Running nose, Rash, Paresthesia. While these are the most often observed Revolade 50 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Revolade 50 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Revolade 50 Tablet is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Revolade 50 Tablet's effects on the liver, heart and kidney are discussed below in the Revolade 50 Tablet related warnings section.
Revolade 50 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Revolade 50 Tablet in conditions like Hepatitis C, Liver Disease. The section on Revolade 50 Tablet contraindications lists all such conditions.
Drug interactions for Revolade 50 Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Revolade 50 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Revolade 50 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 2 - 12 years (Child) |
|
| 13 - 18 years (Adolescent) |
|
| Infant (1 month to 2 years) |
|
Is the use of Revolade 50 Tablet safe for pregnant women?
Revolade can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Revolade right away. Take your doctor's advice before taking it again.
Is the use of Revolade 50 Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Revolade. Immediately discontinue Revolade if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Revolade 50 Tablet on the Kidneys?
There are no side effects of Revolade on the kidneys.
What is the effect of Revolade 50 Tablet on the Liver?
Revolade is rarely harmful for the liver.
What is the effect of Revolade 50 Tablet on the Heart?
There are no any side effects of Revolade for the heart.
If you are suffering from any of the following diseases, you should not take Revolade 50 Tablet unless your doctor advises you to do so -
Is this Revolade 50 Tablet habit forming or addictive?
No, you will not get addicted to Revolade 50 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Revolade 50 Tablet. So it is best to avoid driving.
Is it safe?
Revolade 50 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Revolade 50 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Revolade 50 Tablet
Taking Revolade 50 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Revolade 50 Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Revolade 50 Tablet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Promacta (eltrombopag)
